TOGETHER, TRANSFORMING LIVES
Can Do MS delivers health and wellness education programs to help families living with MS thrive.
Strengthen Families With MS
100% of your gift helps bring life-changing education programs to families in need.
Janssen Announces U.S. FDA Approval of PONVORY™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis
TITUSVILLE, N.J., March 19, 2021 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.+
SKI for MS, a fundraising ski event benefiting families living with multiple sclerosis (MS), has gone virtual for the 2021 season.+
To support their charity partners in the wake of the COVID-19 pandemic, and help offset the expense of measures each organization has implemented to assist their clients, Color Street is donating $10,000 to each of their 30 2018-2020 awareness campaign charity partners.+
This September, show the world how you #ThriveWithMS to inspire others and spread awareness of multiple sclerosis
Can Do Multiple Sclerosis, a non-profit that delivers health and wellness education programs for families with MS, launched their annual, online campaign today that encourages people living with MS, as well as their friends and supporters, to share how they thrive with MS during September’s Can Do Month celebration.